Chiasma
Get Full AccessDescription
- Chiasma is a late-stage biopharmaceutical company focused on improving the lives of patients suffering from orphan diseases by developing and commercializing novel oral forms of therapies that are available today only by injection. The companys lead product candidate is octreotide capsules for the orphan condition acromegaly. Chiasma is evaluating additional proteins, peptides and small molecule drugs that are currently only available by injection, but could potentially be converted to oral delivery using the companys TPE® technology. Chiasma is a Delaware corporation with a wholly owned Israeli subsidiary.
-
Headquarters:140 Kendrick Street , Needham, Massachusetts, United States
More -
Phone Number: +1 617-928-5300
-
Website: https://www.chiasmapharma.com
-
Employees:86
-
Revenue:$100 - 250M
-
Legal Name:Chiasma
-
Chiasma's Social Media
-
Is this data correct?
-
| NAICS Code: 621999 |
Show More
Sell more in less time!
Buyer intent data, anonymous visitor identification, first party data integration backed by a massive contact database that will supercharge your sales team. Schedule a demo to learn more!
Frequently Asked Questions regarding Chiasma
-
Where are Chiasma's Headquarters?
Chiasma's Headquarters are in 140 Kendrick Street ,Needham,Massachusetts,United States
-
What is Chiasma's phone number?
Chiasma's phone number is +1 617-928-5300
-
What is Chiasma's official website?
Chiasma's official website is https://www.chiasmapharma.com
-
What is Chiasma's Revenue?
Chiasma's revenue is $100 - 250M
-
What is Chiasma's NAICS code?
Chiasma's NAICS code is 621999
-
How many employees are working in Chiasma
Chiasma has 86 employees
-
What is Chiasma's Industry?
Chiasma is in the industry of Biotechnology
-
Who is Chiasma's Vice President Of Finance And Administration?
Chiasma's Vice President Of Finance And Administration is Drew Enamait